Quick Overview: Stephen Baylin, M.D., Johns Hopkins Kimmel Stephen Baylin, M.D., at the Johns Hopkins Kimmel Stephen Baylin, M.D., discusses the potential clinical implications from

Decoding The Brain Cancer Genome - Detailed Overview & Context

Stephen Baylin, M.D., Johns Hopkins Kimmel Stephen Baylin, M.D., at the Johns Hopkins Kimmel Stephen Baylin, M.D., discusses the potential clinical implications from ... of experiments that we can do to understand Northwestern Medicine is now one of few institutions worldwide to use methylation profiling for the diagnosis of Bert Vogelstein M.D., discusses the clinical implications of mapping pancreatic and

Frank Attenello, MD, a neurosurgeon at Keck Medicine of USC, discusses the nature of primary Raúl Rabadán, Columbia University Join group to receive calendar invite: ... Victor Velculescu M.D., Ph.D., discusses the analysis of pancreatic and Kenneth Kinzler, M.D., Ph.D discusses why Pascal O. Zinn, MD, PhD, FAANS Dr. Zinn will discuss his experience leveraging state-of-the-art techniques for

Photo Gallery

Decoding the Brain Cancer Genome
Decoding the Brain Cancer Genome - Genetics and Epigenetics
Decoding the Brain Cancer Genome - Clinical Implications
Decoding a Cancer Genome
DNA Methylation Profiling: A Groundbreaking Diagnostic Tool for Brain Tumors
Pancreatic and Brain Cancer Genomes-Clinical Implications
How to Read a Cancer Genome | Part 1: The basics of cancer genomics
Glioma Brain Tumors: Surgical Therapies and Current Genetic Studies
Brief History of Cancer Genomics:Towards Reading the Dark Cancer Genome
Research in 60 seconds: Cicardian clocks & brain cancer
Molecular Profiling of Brain Tumors
Pancreatic and Brain Cancer Genomes - Why Pancreatic?
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored